Clinical Effectiveness of the 0.19-mg Fluocinolone Acetonide (FAc) Intravitreal Implant for Diabetic Macular Edema: Anatomic, Visual and Treatment Burden Outcomes

被引:0
|
作者
Morozova, Christine [1 ]
Humayun, Lucas [1 ,2 ]
Tabandeh, Homayoun [1 ]
Boyer, David S. [1 ]
Dayani, Pouya N. [1 ,3 ]
Rahhal, Firas M. [1 ,3 ]
机构
[1] Retina Vitreous Associates Med Grp, Los Angeles, CA USA
[2] Duke Univ, Durham, NC USA
[3] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
2652
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Efficacy and Safety of 0.19-mg Fluocinolone Acetonide Implant in Postoperative Cystoid Macular Edema after Pars Plana Vitrectomy
    Motloch, Karolina
    Soler, Vincent
    Delyfer, Marie-Noelle
    Vasseur, Vivien
    Wolff, Benjamin
    Issa, Mohamad
    Dot, Corinne
    Masse, Helene
    Weber, Michel
    Comet, Alban
    Hitzl, Wolfgang
    Matonti, Frederic
    Creuzot-Garcher, Catherine
    Tadayoni, Ramin
    Kodjikian, Laurent
    Couturier, Aude
    OPHTHALMOLOGY RETINA, 2024, 8 (12): : 1181 - 1191
  • [42] Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)
    McCluskey, Jessica D.
    Kaufman, Paul L.
    Wynne, Kathy
    Lewis, Gregory
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2019, 12 : 93 - 102
  • [43] Challenging Clinical Cases - A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)
    Pessoa, Bernardete
    Melo-Beirao, Joao
    Meireles, Angelina
    Meneres, Pedro
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2020, 13 : 437 - 448
  • [44] Early treatment with the 0.19 mg fluocinolone acetonide implant is associated with improved functional and anatomical outcomes in patients with persistent or recurrent diabetic macular edema
    Pessoa, Bernardete
    Silva, Nisa
    Marta, Ana
    Coelho, Joao
    Beirao, Melo
    Meireles, Angelina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [45] Persistent or Recurrent Diabetic Macular Edema After Fluocinolone Acetonide 0.19 mg Implant: Risk Factors and Management
    Cicinelli, Maria Vittoria
    Rabiolo, Alessandro
    Zollet, Piero
    Capone, Luigi
    Lattanzio, Rosangela
    Bandello, Francesco
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 215 : 14 - 24
  • [46] Ocular, Visual, and Anatomical Outcomes in Eyes Requiring Incisional Intraocular Pressure-Lowering Surgery Following the 0.19-mg Fluocinolone Acetonide Intravitreal Implant
    Eichenbaum, David
    Gonzalez, Victor H.
    Roth, Daniel
    Fortun, Jorge
    Radcliffe, Nathan M.
    Cutino, Antonio
    Kasper, Jonathan
    Coughlin, Brandon A.
    Arevalo, J. Fernando
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2024, 55 (01): : 22 - 29
  • [47] Evaluation of the clinical effectiveness in routine practice of fluocinolone acetonide 190 μg intravitreal implant in people with diabetic macular edema
    Holden, Sarah E.
    Currie, Craig J.
    Owens, David R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 : 5 - 17
  • [48] Optical Coherence Tomography Biomarkers - Vitreous Status Influence in Outcomes for Diabetic Macular Edema Therapy with 0.19 mg Fluocinolone Acetonide Implant
    Ferreira, Andre
    Oliveira Leite, Joao Miguel
    Melo-Beirao, Joao Nuno
    Meireles, Angelina
    Pessoa, Bernardete
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [49] Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant
    Ciulla, Thomas A.
    Harris, Alon
    McIntyre, Nathaniel
    Jonescu-Cuypers, Christian
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 953 - 959
  • [50] The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular edema
    Cicinelli, Maria Vittoria
    Rosenblatt, Amir
    Grosso, Domenico
    Zollet, Piero
    Capone, Luigi
    Rabiolo, Alessandro
    Lattanzio, Rosangela
    Loewenstein, Anat
    Bandello, Francesco
    EYE, 2021, 35 (12) : 3232 - 3242